AAAAAA

   
Results: 1-10 |
Results: 10
Effects of growth hormone (GH) administration on homocyst(e)ine levels in men with GH deficiency: A randomized controlled trial
Authors: Sesmilo, G Biller, BMK Llevadot, J Hayden, D Hanson, G Rifai, N Klibanski, A
Citation: G. Sesmilo et al., Effects of growth hormone (GH) administration on homocyst(e)ine levels in men with GH deficiency: A randomized controlled trial, J CLIN END, 86(4), 2001, pp. 1518-1524
Clinical and reimbursement issues in growth hormone use in adults
Authors: Biller, BMK Vance, ML Kleinberg, DL Cook, DM Gordon, T
Citation: Bmk. Biller et al., Clinical and reimbursement issues in growth hormone use in adults, AM J M CARE, 6(15), 2000, pp. S817-S827
Withdrawal of long-term physiological growth hormone (GH) administration: Differential effects on bone density and body composition in men with adult-onset GH deficiency
Authors: Biller, BMK Sesmilo, G Baum, HBA Hayden, D Schoenfeld, D Klibanski, A
Citation: Bmk. Biller et al., Withdrawal of long-term physiological growth hormone (GH) administration: Differential effects on bone density and body composition in men with adult-onset GH deficiency, J CLIN END, 85(3), 2000, pp. 970-976
Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency - A randomized, controlled clinical trial
Authors: Sesmilo, G Biller, BMK Llevadot, J Hayden, D Hanson, G Rifai, N Klibanski, A
Citation: G. Sesmilo et al., Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency - A randomized, controlled clinical trial, ANN INT MED, 133(2), 2000, pp. 111-122
Hyperprolactinemia
Authors: Biller, BMK
Citation: Bmk. Biller, Hyperprolactinemia, INT J F W M, 44(2), 1999, pp. 74-77
Guidelines for the diagnosis and treatment of hyperprolactinemia
Authors: Biller, BMK Luciano, A Crosignani, PG Molitch, M Olive, D Rebar, R Sanfilippo, J Webster, J Zacur, H
Citation: Bmk. Biller et al., Guidelines for the diagnosis and treatment of hyperprolactinemia, J REPRO MED, 44(12), 1999, pp. 1075-1084
Diagnostic evaluation of hyperprolactinemia
Authors: Biller, BMK
Citation: Bmk. Biller, Diagnostic evaluation of hyperprolactinemia, J REPRO MED, 44(12), 1999, pp. 1095-1099
Long-term mortality after transsphenoidal surgery for Cushing disease
Authors: Swearingen, B Biller, BMK Barker, FG Katznelson, L Grinspoon, S Klibanski, A Zervas, NT
Citation: B. Swearingen et al., Long-term mortality after transsphenoidal surgery for Cushing disease, ANN INT MED, 130(10), 1999, pp. 821-824
A new clinical option for hormone replacement therapy in women with secondary amenorrhea: Effects of cyclic administration of progesterone from the sustained-release vaginal gel Crinone (4% and 8%) on endometrial morphologicfeatures and withdrawal bleeding
Authors: Warren, MP Biller, BMK Shangold, MM
Citation: Mp. Warren et al., A new clinical option for hormone replacement therapy in women with secondary amenorrhea: Effects of cyclic administration of progesterone from the sustained-release vaginal gel Crinone (4% and 8%) on endometrial morphologicfeatures and withdrawal bleeding, AM J OBST G, 180(1), 1999, pp. 42-48
Efficacy of growth hormone-replacement therapy: Body composition and bone density
Authors: Biller, BMK
Citation: Bmk. Biller, Efficacy of growth hormone-replacement therapy: Body composition and bone density, ENDOCRINOLO, 8(6), 1998, pp. 15S-21S
Risultati: 1-10 |